Bidirectional roles of nanoenzymes in enhancing GPC3-CAR T cell infiltration and cancer immunotherapy

Abstract Background Vascular abnormalities and hypoxia in solid tumors limit the efficacy of chimeric antigen receptor (CAR) T-cell therapy. This study proposes a biomimic nanoenzyme, Lenv@BSA-PtNPs, combining platinum nanoparticles (PtNPs) and lenvatinib, to address these challenges in a hepatocell...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Xu, Jianping Liao, Jiahong Wang, Yuan Gao, Yuan Wu, Meiqin Gao, Wenwen Liu, Da Zhang, Wenmin Zhang, Aimin Huang
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-025-06636-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850218547003785216
author Yu Xu
Jianping Liao
Jiahong Wang
Yuan Gao
Yuan Wu
Meiqin Gao
Wenwen Liu
Da Zhang
Wenmin Zhang
Aimin Huang
author_facet Yu Xu
Jianping Liao
Jiahong Wang
Yuan Gao
Yuan Wu
Meiqin Gao
Wenwen Liu
Da Zhang
Wenmin Zhang
Aimin Huang
author_sort Yu Xu
collection DOAJ
description Abstract Background Vascular abnormalities and hypoxia in solid tumors limit the efficacy of chimeric antigen receptor (CAR) T-cell therapy. This study proposes a biomimic nanoenzyme, Lenv@BSA-PtNPs, combining platinum nanoparticles (PtNPs) and lenvatinib, to address these challenges in a hepatocellular carcinoma (HCC) nonobese diabetic (NOD) mice model. Methods Lenv@BSA-PtNPs were designed using albumin as a solubilizer, embedding lenvatinib via hydrophobic interactions and facilitating in situ PtNPs generation. The nanoenzyme functions as a catalase, converting H2O2 to O2, downregulating hypoxia-inducible factor (HIF-1), and normalizing tumor vasculature. Its efficacy was evaluated in a glypican-3 (GPC3)-CAR T-cell therapy model for HCC. Results Lenv@BSA-PtNPs significantly improved tumor oxygenation, normalized vasculature, and enhanced GPC3-CAR T-cell infiltration into tumors. This led to potent antitumor effects and prolonged survival in the HCC mouse model. Conclusions Lenv@BSA-PtNPs provide a simple and effective strategy to enhance CAR-T cell accumulation and efficacy by ameliorating hypoxia and normalizing tumor vasculature, offering a promising approach for improving CAR-T therapy in solid tumors.
format Article
id doaj-art-a56a594fcb0044ea919f1febebdcea7a
institution OA Journals
issn 1479-5876
language English
publishDate 2025-06-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-a56a594fcb0044ea919f1febebdcea7a2025-08-20T02:07:41ZengBMCJournal of Translational Medicine1479-58762025-06-0123111510.1186/s12967-025-06636-7Bidirectional roles of nanoenzymes in enhancing GPC3-CAR T cell infiltration and cancer immunotherapyYu Xu0Jianping Liao1Jiahong Wang2Yuan Gao3Yuan Wu4Meiqin Gao5Wenwen Liu6Da Zhang7Wenmin Zhang8Aimin Huang9Department of Pathology, School of Basic Medical Sciences, Fujian Medical UniversityDepartment of Pathology, School of Basic Medical Sciences, Fujian Medical UniversityDepartment of Pathology, School of Basic Medical Sciences, Fujian Medical UniversityDepartment of Pathology, School of Basic Medical Sciences, Fujian Medical UniversityDepartment of Pathology, School of Basic Medical Sciences, Fujian Medical UniversityDepartment of Pathology, School of Basic Medical Sciences, Fujian Medical UniversityDepartment of Pathology, School of Basic Medical Sciences, Fujian Medical UniversityDepartment of Pathology, School of Basic Medical Sciences, Fujian Medical UniversityDepartment of Pathology, School of Basic Medical Sciences, Fujian Medical UniversityDepartment of Pathology, School of Basic Medical Sciences, Fujian Medical UniversityAbstract Background Vascular abnormalities and hypoxia in solid tumors limit the efficacy of chimeric antigen receptor (CAR) T-cell therapy. This study proposes a biomimic nanoenzyme, Lenv@BSA-PtNPs, combining platinum nanoparticles (PtNPs) and lenvatinib, to address these challenges in a hepatocellular carcinoma (HCC) nonobese diabetic (NOD) mice model. Methods Lenv@BSA-PtNPs were designed using albumin as a solubilizer, embedding lenvatinib via hydrophobic interactions and facilitating in situ PtNPs generation. The nanoenzyme functions as a catalase, converting H2O2 to O2, downregulating hypoxia-inducible factor (HIF-1), and normalizing tumor vasculature. Its efficacy was evaluated in a glypican-3 (GPC3)-CAR T-cell therapy model for HCC. Results Lenv@BSA-PtNPs significantly improved tumor oxygenation, normalized vasculature, and enhanced GPC3-CAR T-cell infiltration into tumors. This led to potent antitumor effects and prolonged survival in the HCC mouse model. Conclusions Lenv@BSA-PtNPs provide a simple and effective strategy to enhance CAR-T cell accumulation and efficacy by ameliorating hypoxia and normalizing tumor vasculature, offering a promising approach for improving CAR-T therapy in solid tumors.https://doi.org/10.1186/s12967-025-06636-7NanoenzymeVascular normalizationHypoxiaGPC3-CAR T cells immunity
spellingShingle Yu Xu
Jianping Liao
Jiahong Wang
Yuan Gao
Yuan Wu
Meiqin Gao
Wenwen Liu
Da Zhang
Wenmin Zhang
Aimin Huang
Bidirectional roles of nanoenzymes in enhancing GPC3-CAR T cell infiltration and cancer immunotherapy
Journal of Translational Medicine
Nanoenzyme
Vascular normalization
Hypoxia
GPC3-CAR T cells immunity
title Bidirectional roles of nanoenzymes in enhancing GPC3-CAR T cell infiltration and cancer immunotherapy
title_full Bidirectional roles of nanoenzymes in enhancing GPC3-CAR T cell infiltration and cancer immunotherapy
title_fullStr Bidirectional roles of nanoenzymes in enhancing GPC3-CAR T cell infiltration and cancer immunotherapy
title_full_unstemmed Bidirectional roles of nanoenzymes in enhancing GPC3-CAR T cell infiltration and cancer immunotherapy
title_short Bidirectional roles of nanoenzymes in enhancing GPC3-CAR T cell infiltration and cancer immunotherapy
title_sort bidirectional roles of nanoenzymes in enhancing gpc3 car t cell infiltration and cancer immunotherapy
topic Nanoenzyme
Vascular normalization
Hypoxia
GPC3-CAR T cells immunity
url https://doi.org/10.1186/s12967-025-06636-7
work_keys_str_mv AT yuxu bidirectionalrolesofnanoenzymesinenhancinggpc3cartcellinfiltrationandcancerimmunotherapy
AT jianpingliao bidirectionalrolesofnanoenzymesinenhancinggpc3cartcellinfiltrationandcancerimmunotherapy
AT jiahongwang bidirectionalrolesofnanoenzymesinenhancinggpc3cartcellinfiltrationandcancerimmunotherapy
AT yuangao bidirectionalrolesofnanoenzymesinenhancinggpc3cartcellinfiltrationandcancerimmunotherapy
AT yuanwu bidirectionalrolesofnanoenzymesinenhancinggpc3cartcellinfiltrationandcancerimmunotherapy
AT meiqingao bidirectionalrolesofnanoenzymesinenhancinggpc3cartcellinfiltrationandcancerimmunotherapy
AT wenwenliu bidirectionalrolesofnanoenzymesinenhancinggpc3cartcellinfiltrationandcancerimmunotherapy
AT dazhang bidirectionalrolesofnanoenzymesinenhancinggpc3cartcellinfiltrationandcancerimmunotherapy
AT wenminzhang bidirectionalrolesofnanoenzymesinenhancinggpc3cartcellinfiltrationandcancerimmunotherapy
AT aiminhuang bidirectionalrolesofnanoenzymesinenhancinggpc3cartcellinfiltrationandcancerimmunotherapy